Study on Expression and Significance of CD44v6 in Endometrial Adenocarcinoma of Uterus

项达军,冯一中,薛文群,陆以农,陈萍倩,王嘉园

DOI: https://doi.org/10.3969/j.issn.1673-0399.2002.04.006

2002-01-01

Abstract:objective The aim is to study the effects of the gene expression of CD44v6 on oncogenesis and progression of endometrial carcinoma.Methods The expression levels of CD44v6 were studied by S-P immunohistochemistry method in 55 cases of endometrial adenocarcinoma and 10 cases of normal proliferatic,simple hyperplastic and atypical endometrium respectively.Their relationship relating with clinicopathological features and surrival was also investigated.Results (1)The expression of CD44v6 increased progressively from normal proliferatic,simple hyperplastic and atypical hyperplastic endometrium to adenocarcinoma,whose ratios were 10%,40%,60% and 78.18% respectively,showing high significant difference( P 0.001),The CD44v6 expression in 55 cases of carcinoma was inversely associated with surgical stages and metastasis of lymph nodes ( P0.05,P 0.01),while no significant difference was detected in different myometrial invasion and histologic grade.(2)the analysis of single factor revealed that the expression of CD44v6 was significantly related with the prognosis of patients ( P 0.001).Analyzed by Cox proportion hazard model,it showed that the prognosis was independently affected by age,surgical surgical stage and CD44v6,and that the prognosis of patients with negative expression of CD44v6,and that the prognosis of patients with negative expression of CD44v6 had a shorter average survival time than that had positive expression.Conclusion The experiment suggests that CD44v6 play roles in oncogenesis and progression of endometrial adenocarcinoma.The negative expression of CD44v6 indicate poor prognosis of endometrial adenocarcinoma